For children and adolescents with multiple sclerosis (MS), receiving treatment with Copaxone (glatiramer acetate) or its generic formulations…
Articles by Margarida Maia, PhD
People genetically prone to a higher body mass index (BMI) are also more likely to develop multiple sclerosis (MS),…
People who develop multiple sclerosis (MS) begin using healthcare services more frequently up to 15 years before their first…
Lucid-MS, an oral small-molecule being developed by Quantum Biopharma for treating multiple sclerosis (MS), was found to be…
Neurofilament light chain (NfL) — a protein that gets released when nerve cells are damaged — is found at high…
In progressive forms of multiple sclerosis (MS), treatment with estrogen hormones such as estradiol may help reduce inflammation and nerve…
People with multiple sclerosis (MS) are significantly more likely to visit an emergency department if they have other health…
Regular exercise that follows established guidelines for physical activity in multiple sclerosis (MS) leads to clinically meaningful gains in…
People with multiple sclerosis (MS) visited doctors, were admitted to the hospital, and used emergency care more often than…
The rates of people with multiple sclerosis (MS) who advance from a relapsing disease course to a secondary progressive…
Following the MIND diet plan, rich in leafy greens, whole grains, legumes, nuts, berries, and lean meats, may help strengthen…
In healthy adults, a single low dose of Immutep’s immunosuppressive candidate IMP761 continues to be safe and appears to…
People who develop multiple sclerosis (MS) at a younger age tend to consistently have better physical health but worse…
Ambio Life Sciences has launched a clinical program to test ibogaine — an experimental, naturally occurring psychedelic — for…
Enrollment is now complete in the twin Phase 3 clinical trials testing Immunic Therapeutics‘ oral small molecule vidofludimus…
Body mass index (BMI), a measure commonly used measure of body fat based on a person’s height and weight, does…
Almost two years of treatment with fenebrutinib — an investigational oral tablet for multiple sclerosis (MS) — helped…
While subtle symptoms of multiple sclerosis (MS) — like muscle weakness, fatigue, and numbness or unusual sensations — are…
Half of multiple sclerosis (MS) patients in the U.K. who work have compromised their health by staying in jobs…
A 10-week program that combines cognitive behavioral therapy — a technique focused on understanding the connection between thoughts, feelings, and…
Stem cells from donated placentas appear safe and may help reduce symptoms of secondary progressive multiple sclerosis (MS), according…
Three months of daily supplements containing ellagic acid — an antioxidant found naturally in many fruits and plants — significantly…
Non-pharmacological interventions such as mindfulness and exercise may improve sleep for people with multiple sclerosis (MS) while boosting overall…
As multiple sclerosis (MS) progresses, the disease may reduce the number of mitochondrial DNA copies, suggesting the number of…
Injections of methotrexate into the spinal canal given every three months were safe and well tolerated, and helped adults with…
Vidofludimus calcium, an experimental oral therapy from Immunic Therapeutics, reduced the risk of confirmed disability worsening and slowed brain…
The healthcare costs of secondary progressive multiple sclerosis (SPMS) are high, according to a real-world study in Spain, and…
Biostate AI is partnering with the nonprofit Accelerated Cure Project (ACP) to develop a series of artificial intelligence (AI)…
Frexalimab, an experimental antibody-based medication, was well tolerated and maintained disease control over two years in adults with relapsing forms…
A Phase 4 observational study called ENABLE is enrolling adults with relapsing forms of multiple sclerosis (MS) across the…